Protocol of the randomized control trial: the WiseApp trial for improving health outcomes in PLWH (WiseApp)

Gabriella Flynn, Haomiao Jia, Nancy R Reynolds, David C Mohr, Rebecca Schnall, Gabriella Flynn, Haomiao Jia, Nancy R Reynolds, David C Mohr, Rebecca Schnall

Abstract

Background: Poor adherence to antiretroviral therapy (ART) is one of the primary barriers to viral load suppression. mHealth technology can help overcome challenges with ART adherence. This paper outlines the protocol for the WiseApp randomized control trial. The WiseApp contains real-time medication monitoring linking an electronic pill bottle and fitness tracker to the app, helping persons living with HIV (PLWH) self-manage their medication adherence and improve their overall quality of life. The primary objective of the trial is to test the effect of the WiseApp's medication adherence features on antiretroviral adherence in underserved PLWH in New York City.

Methods: This ongoing study is a two-arm randomized control trial. Participants are randomized 1:1 to the WiseApp intervention arm or the control arm at baseline and followed for 6 months. Eligibility criteria include: 18 years of age, have a diagnosis of HIV, speak and understand English or Spanish, live in the United States, own a smartphone, currently taking ART medications, and report the past 30 days adherence of 80% or less as measured using the Visual Analogue Scale (VAS), or have a viral load of over 400 copies/mL. The sample size for the trial is 200 people. All study participants receive the WiseApp, a CleverCap electronic pill bottle, and a fitness tracker. The intervention group also receives videos and health surveys centered on medication adherence and managing living with HIV as well as medication reminders. In contrast, the control group receives walk step reminders, videos, and surveys focused on overall wellness.

Discussion: The WiseApp Trial has the potential to improve HIV self-management applications, being one of the few randomized controlled trials of a mHealth medication adherence and HIV self-management application in the United States. The trial could also bring new opportunities for advancement in reaching economically disenfranchised and underserved populations in the United States. The real-time monitoring of the WiseApp has the potential to help providers initiate interventions to help patients resume treatment before drug resistance begins.

Trial registration: This trial was registered with ClinicalTrials.gov ( NCT03205982 ) on July 2, 2017.

Keywords: HIV/AIDS; Medication adherence; Mobile health; Randomized controlled trial; Real-time monitoring.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
WiseApp schematic diagram
Fig. 2
Fig. 2
WiseApp study materials: WiseApp, CleverCap pill bottle, and fitness tracker. The intervention group receives videos and health surveys; all centered on medication adherence and managing living with HIV. A summary comparing the intervention vs. the control group is outlined below in Table 1. The intervention group’s “To Do” list serves as daily reminders for medication adherence tracking, walk steps, and completing their weekly videos and surveys. As mentioned, the CleverCap pill bottle and the fitness tracker are both linked to the WiseApp. The history tab on the WiseApp shows the intervention group’s medication adherence with green bars showing that they completed taking their medication for the day and red bars showing when they missed a day (Fig. 2). They receive daily app notification reminders for taking their medication

References

    1. HIV Basic Statistics, (2020, Accessed May 14 2020).
    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382:1525–1533. doi: 10.1016/S0140-6736(13)61809-7.
    1. Gardner EM, McLees MP, Steiner JF, et al. The Spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800. doi: 10.1093/cid/ciq243.
    1. Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquired Immune Deficiency Syndromes. 2000;24:123–128. doi: 10.1097/00042560-200006010-00006.
    1. Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis 2007; 45: 127–130. 2007/06/08. DOI: 10.1086/518587.
    1. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3: e438. 2006/11/24. DOI: 10.1371/journal.pmed.0030438.
    1. NYS HIV Surveillance System. HIV care continuum - people living with HIV, New York state (2018). 2019.
    1. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J General Internal Med 2002; 17: 756–765. Article. DOI: 10.1046/j.1525-1497.2002.11214.x.
    1. Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS 2006; 20: 223–231. 2006/03/03. DOI: 10.1097/01.aids.0000199825.34241.49.
    1. Wainberg MA and Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998; 279: 1977-1983. 1998/06/27. DOI: 10.1001/jama.279.24.1977.
    1. Kumar S, Nilsen WJ, Abernethy A, et al. Mobile health technology evaluation: the mHealth evidence workshop. Am J Prev Med 2013; 45: 228–236. 2013/07/23. DOI: 10.1016/j.amepre.2013.03.017.
    1. Estrin D and Sim I. Health care delivery. Open mHealth architecture: an engine for health care innovation. Science 2010; 330: 759–760. 2010/11/06. DOI: 10.1126/science.1196187.
    1. Schnall R, Rojas M, Travers J, et al. Use of Design Science for Informing the Development of a Mobile App for Persons Living with HIV. AMIA Annual Symposium proceedings AMIA Symposium 2014; 2014: 1037–1045. 2014/01/01.
    1. Beauchemin M, Gradilla M, Baik D, et al. A Multi-step Usability Evaluation of a Self-Management App to Support Medication Adherence in Persons Living with HIV. Int J Med Informatics 2019; 122: 37–44. DOI: 10.1016/j.ijmedinf.2018.11.012.
    1. Folstein MF, Folstein SE and McHugh PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12: 189–198. DOI: 10.1016/0022-3956(75)90026-6.
    1. Altman DG and Bland JM. Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ 1999; 318: 1209. 1999/04/30. DOI: 10.1136/bmj.318.7192.1209.
    1. Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14:1340–1346. doi: 10.1007/s10461-010-9799-4.
    1. Fogg BJ. Persuasive technology: using computers to change what we think and do. Ubiquity 2002; 2002: Article 5. DOI: 10.1145/764008.763957.
    1. Tudor-Locke C, Craig CL, Thyfault JP, et al. A step-defined sedentary lifestyle index: <5000 steps/day. Appl Physiol Nutr Metab. 2012;38:100–114. doi: 10.1139/apnm-2012-0235.
    1. Tudor-Locke C, Bassett DR. How many steps/day are enough? Sports Med. 2004;34:1–8. doi: 10.2165/00007256-200434010-00001.
    1. Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158:1789–1795. doi: 10.1001/archinte.158.16.1789.
    1. American Psychiatric Association Adapted NIDA Modified ASSIST Tools, (2015).
    1. Weiss BD, Mays MZ, Martz W, et al. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med 2005; 3: 514–522. 2005/12/13. DOI: 10.1370/afm.405.
    1. Parker RM, Baker DW, Williams MV, et al. The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills. J Gen Intern Med 1995; 10: 537–541. 1995/10/01. DOI: 10.1007/bf02640361.
    1. Hays RD, Sherbourne CD and Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 217–227. 1993/10/01. DOI: 10.1002/hec.4730020305.
    1. Marc LG, Wang MM and Testa MA. Psychometric evaluation of the HIV symptom distress scale. AIDS Care 2012; 24: 1432–1441. 2012/03/14. DOI: 10.1080/09540121.2012.656567.
    1. Viney R, Norman R, Brazier J, et al. An Australian discrete choice experiment to value eq-5d health states. Health Econ 2014; 23: 729–742. 2013/06/15. DOI: 10.1002/hec.2953.
    1. Webel AR, Asher A, Cuca Y, et al. Measuring HIV self-management in women living with HIV/AIDS: a psychometric evaluation study of the HIV Self-management Scale. J Acquir Immune Defic Syndr 2012; 60: e72–81. 2012/05/10. DOI: 10.1097/QAI.0b013e318256623d.
    1. Hertogh EM, Monninkhof EM, Schouten EG, et al. Validity of the modified Baecke questionnaire: comparison with energy expenditure according to the doubly labeled water method. Int J Behav Nutr Phys Act 2008; 5: 30. 2008/05/29. DOI: 10.1186/1479-5868-5-30.
    1. Reynolds WM. Development of reliable and valid short forms of the Marlowe-Crowne social desirability scale. J Clin Psychol. 1982;38:119–125. doi: 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>;2-I.
    1. National Health and Nutrition Examination Survey III (NHANES III). Body Measurements (Anthropometry).
    1. Centers for Disease Control and Prevention NCfHS. National Health and Nutrition Examination Study (NHANES) Anthropometry Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services: Department of Health and Human Services, Centers for Disease Control and Prevention, 2007–2008.
    1. Albanese T, Wood M, Spellmna B. Housing status assessment guide for state TANF and Medicaid programs. Bethesda, MD: U.S. Department of Health and Human Services; 2009.
    1. Mannheimer SB, Mukherjee R, Hirschhorn LR, et al. The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care 2006; 18: 853–861. 2006/09/15. DOI: 10.1080/09540120500465160.
    1. Bakken S, Holzemer WL, Brown MA, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS 2000; 14: 189–197. 2000/05/12. DOI: 10.1089/108729100317795.
    1. Schnall R, Cho H, Liu J. Health Information Technology Usability Evaluation Scale (Health-ITUES) for Usability Assessment of Mobile Health Technology: Validation Study. JMIR Mhealth Uhealth. 2018;6:e4. doi: 10.2196/mhealth.8851.
    1. Lewis JR. Psychometric evaluation of the PSSUQ using data from five years of usability studies. Int J Human–Computer Interaction. 2002;14:463–488. doi: 10.1080/10447318.2002.9669130.
    1. Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;13:319–340. doi: 10.2307/249008.
    1. Norman CD and Skinner HA. eHEALS: The eHealth Literacy Scale. J Med Internet Res 2006; 8: e27. 2007/01/11. DOI: 10.2196/jmir.8.4.e27.
    1. Chen X, Hay JL, Waters EA, et al. Health literacy and use and Trust in Health Information. J Health Commun. 2018;23:724–734. doi: 10.1080/10810730.2018.1511658.
    1. Rosenberg D, Ding D, Sallis JF, et al. Neighborhood Environment Walkability Scale for Youth (NEWS-Y): Reliability and relationship with physical activity. Preventive Medicine. 2009;49:213–218. doi: 10.1016/j.ypmed.2009.07.011.
    1. O’Brien MS, Burdsal CA, Molgaard CA. Further development of an Australian-based measure of social capital in a US sample. Social Sci Med. 2004;59:1207–1217. doi: 10.1016/j.socscimed.2004.01.007.
    1. Resnick B, Jenkins LS. Testing the reliability and validity of the self-efficacy for exercise scale. Nurs Res. 2000;49.
    1. Research NIoN. The NINR strategic plan: advancing science, improving lives. 2016.
    1. Sidney K, Antony J, Rodrigues R, et al. Supporting patient adherence to antiretrovirals using mobile phone reminders: patient responses from South India. AIDS Care. 2012;24:612–617. doi: 10.1080/09540121.2011.630357.
    1. Catalani C, Philbrick W, Fraser H, et al. mHealth for HIV Treatment & Prevention: a systematic review of the literature. Open AIDS J. 2013;7:17–41. doi: 10.2174/1874613620130812003.
    1. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152:54–13. doi: 10.7326/0003-4819-152-1-201001050-00012.
    1. Muessig KE, LeGrand S, Horvath KJ, et al. Recent mobile health interventions to support medication adherence among HIV-positive MSM. Curr Opin HIV AIDS. 2017;12:432–441. doi: 10.1097/COH.0000000000000401.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe